Stem cell-derived retinal pigment epithelium transplantation in age-related macular degeneration: recent advances and challenges

医学 诱导多能干细胞 黄斑变性 临床试验 胚胎干细胞 干细胞 视网膜色素上皮 移植 干细胞疗法 细胞疗法 生物信息学 视网膜 眼科 病理 外科 生物 基因 生物化学 遗传学
作者
Amir H. Kashani
出处
期刊:Current Opinion in Ophthalmology [Lippincott Williams & Wilkins]
卷期号:33 (3): 211-218 被引量:14
标识
DOI:10.1097/icu.0000000000000838
摘要

Purpose of review Age-related macular degeneration (AMD) is one of the leading causes of irreversible vision loss in the world with more than 80% of the prevalence accounted for by the nonneovascular (NNAMD) or ‘dry’ form of the disease. NNAMD does not have any definitive treatment once vision loss has ensued and presents a major unmet medical need. This review will highlight stem cell-based therapies that are a promising form of treatment for advanced NNAMD. Recent findings In the past decade, clinical trials utilizing both induced pluripotent stem cell-derived RPE and human embryonic stem cell-derived RPE have been aggressively pursued as potential treatments of RPE loss and prevention of overlying neurosensory atrophy. While promising preliminary results demonstrating safety and potential efficacy have been published, new challenges have also been identified. These include selecting the most appropriate cell-based therapy, identifying and managing potential immune response as well as characterizing anatomic and functional efficacy. In this review, we will discuss some of these challenges in light of the available data from several early phase clinical trials and discuss the strategies that are being considered to further advance the field. Summary Cell-based therapies demonstrate promising potential to treat advanced stages of NNAMD. Several early phase clinical trials using both induced pluripotent stem cells (iPSC) and human embryonic stem cell derived (hESC) have demonstrated safety and preliminary signs of efficacy and highlighted remaining challenges which appear surmountable. These challenges include development of selection criteria for use of cell suspensions versus RPE sheets, especially in light of immunological properties of RPE that are intrinsic to the status of RPE differentiation in each of these cell formulations.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
xuyeqiao完成签到 ,获得积分10
1秒前
cherry_mm发布了新的文献求助30
2秒前
LWJ要毕业完成签到 ,获得积分10
4秒前
雪山大地发布了新的文献求助10
5秒前
瞬间de回眸完成签到 ,获得积分10
10秒前
情怀的应助被369ninja采纳,获得10
12秒前
zhao完成签到,获得积分10
14秒前
研友_LpvQlZ完成签到,获得积分10
16秒前
丘比特的应助被泥猴桃采纳,获得50
16秒前
唐陌完成签到 ,获得积分10
17秒前
俭朴擎汉完成签到 ,获得积分10
19秒前
Rachel完成签到 ,获得积分10
19秒前
grace完成签到 ,获得积分0
20秒前
桥西小河完成签到 ,获得积分10
21秒前
啦你完成签到 ,获得积分10
22秒前
25秒前
25秒前
alixy完成签到,获得积分10
27秒前
木木 12完成签到,获得积分10
28秒前
文静凝芙完成签到,获得积分10
28秒前
活泼雪莲发布了新的文献求助10
29秒前
可乐大侠完成签到 ,获得积分10
29秒前
萌萌2完成签到,获得积分10
29秒前
慈祥的鸿煊完成签到 ,获得积分10
30秒前
fantasy的应助被369ninja采纳,获得10
31秒前
王不凡完成签到 ,获得积分10
31秒前
Jeffrey完成签到,获得积分10
31秒前
蝈蝈完成签到,获得积分10
32秒前
雪山大地发布了新的文献求助10
33秒前
Echo完成签到,获得积分0
36秒前
JIANG完成签到,获得积分10
38秒前
ARIA完成签到 ,获得积分0
38秒前
群山完成签到 ,获得积分10
39秒前
mongmong完成签到 ,获得积分10
40秒前
41秒前
春夏完成签到 ,获得积分10
41秒前
卢彦冬完成签到,获得积分10
43秒前
44秒前
冷静以山完成签到 ,获得积分10
48秒前
飞儿完成签到 ,获得积分10
50秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166550
求助须知:如何正确求助?哪些是违规求助? 9559535
关于积分的说明 21750720
捐赠科研通 7757357
什么是DOI,文献DOI怎么找? 3429141
关于科研通互助平台的介绍 2553523
邀请新用户注册赠送积分活动 2473904